Drugs / SMC with SP+AQ
last change Mar 2020 re-read 2 minutes ago

SMC with SP+AQ

Developed for
Plasmodium falciparum malaria

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03143218 Comparator Apr 2017 → Mar 2020 Plasmodium falciparum malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SMC with SP+AQ ClinicalTrials.gov intervention name — accepted as the source's own label NCT03143218